Xylazine Exposure Guidance
This correspondence provides updates on the May 2023 Xylazine Exposure Guidance and discusses implications for clinical practice and frontline public health.
Offer evidence-based recommendations for clinicians about the care of patients.
These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder.